NCT00003255View on ClinicalTrials.gov

Carboplatin Plus Topotecan in Treating Patients With Relapsed Acute Myelogenous Leukemia

PHASE2CompletedINTERVENTIONAL
Enrollment

38

Participants

Timeline

Start Date

November 30, 1999

Primary Completion Date

December 31, 2006

Study Completion Date

December 31, 2006

Conditions
Leukemia
Interventions
DRUG

carboplatin

DRUG

topotecan hydrochloride

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Alliance for Clinical Trials in Oncology

OTHER

NCT00003255 - Carboplatin Plus Topotecan in Treating Patients With Relapsed Acute Myelogenous Leukemia | Biotech Hunter | Biotech Hunter